MedChem Products Inc. on Tuesday said it has filed a pre-market approval application with the Food and DrugAdministration for use of its Orthovisc hyaluronic acid productto treat patients with temporomandibular joint dysfunction.The Woburn, Mass., company (AMEX:MCH) hopes to beginmarketing Orthovisc in early 1993.

(c) 1997 American Health Consultants. All rights reserved.